Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adele K Fielding

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
Leukemia & Lymphoma|December 4, 2020
Utility of 18F-FDG-PET/CT in lymphoblastic lymphomaThomas A Fox, Ben Carpenter, Mary Taj, et al.
Blood|April 8, 2010
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioningAdam J Mead, Kirsty J Thomson, Emma C Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemiaAnthony V Moorman, Claire Schwab, Hannah M Ensor, et al.
Blood Advances|December 19, 2023
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative studyAmir Enshaei, Melvin Joy, Ellie Butler, et al.
Leukemia|September 29, 2023
Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platformAmir Enshaei, Javier Martinez Elicegui, Esther Anguiano, et al.
British Journal of Haematology|January 9, 2013
Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemiaSimon E Richardson, Iftekhar Khan, Andrew Rawstron, et al.
Blood Advances|September 3, 2024
Mitochondrial dsRNA from B-ALL cells stimulates mesenchymal stromal cells to become cancer-associated fibroblastsRichard J Burt, Aditi Dey, Ayse Akarca, et al.
Genes, Chromosomes & Cancer|December 30, 2016
Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemiaLisa J Russell, Lisa Jones, Amir Enshaei, et al.
Blood|February 4, 2010
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphomaJonathan R Lambert, Jamshed B Bomanji, Karl S Peggs, et al.
Frontiers in Pharmacology|November 16, 2020
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PROPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
Leukemia & Lymphoma|December 4, 2020
Utility of 18F-FDG-PET/CT in lymphoblastic lymphomaThomas A Fox, Ben Carpenter, Mary Taj, et al.
Blood|April 8, 2010
HLA-mismatched unrelated donors are a viable alternate graft source for allogeneic transplantation following alemtuzumab-based reduced-intensity conditioningAdam J Mead, Kirsty J Thomson, Emma C Morris, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 2, 2012
IGH@ translocations, CRLF2 deregulation, and microdeletions in adolescents and adults with acute lymphoblastic leukemiaAnthony V Moorman, Claire Schwab, Hannah M Ensor, et al.
Blood Advances|December 19, 2023
A robust and validated integrated prognostic index for defining risk groups in adult acute lymphoblastic leukemia: an EWALL collaborative studyAmir Enshaei, Melvin Joy, Ellie Butler, et al.
Leukemia|September 29, 2023
Real-world evaluation of UK high hyperdiploidy profile using a large cohort of patients provided by HARMONY data platformAmir Enshaei, Javier Martinez Elicegui, Esther Anguiano, et al.
British Journal of Haematology|January 9, 2013
Risk-stratified adoptive cellular therapy following allogeneic hematopoietic stem cell transplantation for advanced chronic lymphocytic leukaemiaSimon E Richardson, Iftekhar Khan, Andrew Rawstron, et al.
Blood Advances|September 3, 2024
Mitochondrial dsRNA from B-ALL cells stimulates mesenchymal stromal cells to become cancer-associated fibroblastsRichard J Burt, Aditi Dey, Ayse Akarca, et al.
Genes, Chromosomes & Cancer|December 30, 2016
Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemiaLisa J Russell, Lisa Jones, Amir Enshaei, et al.
Blood|February 4, 2010
Prognostic role of PET scanning before and after reduced-intensity allogeneic stem cell transplantation for lymphomaJonathan R Lambert, Jamshed B Bomanji, Karl S Peggs, et al.
Frontiers in Pharmacology|November 16, 2020
Reliability of a Novel Hematological Malignancy Specific Patient-Reported Outcome Measure: HM-PROPushpendra Goswami, Esther N Oliva, Tatyana Ionova, et al.
Pageof 9